Skip to main content
Erschienen in: AIDS and Behavior 5/2024

16.02.2024 | Original Paper

Association Between Substance Abuse and Mental Illness Symptoms Screener (SAMISS) Scores and HIV Care Continuum Outcomes in People Newly Diagnosed with HIV in the US South

verfasst von: Manal Ahmed, Ank E. Nijhawan, Ang Gao, Chul Ahn, Jeremy Y Chow

Erschienen in: AIDS and Behavior | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Mental illness (MI) and substance use (SU) are highly prevalent among people with HIV (PWH) and impact care outcomes. The Substance Abuse and Mental Illness Symptoms Screener (SAMISS) is a validated screener for MI and SU, but it is unknown how screening results at entry to care correlate with subsequent HIV outcomes. This is a retrospective chart review of individuals newly diagnosed with HIV between 2016 and 2019 in a Southern US, safety-net clinic. Baseline demographics, HIV risk factors, socioeconomic variables, and SAMISS screening scores were collected. Outcomes included retention in care, achieving virologic suppression (VS), and continuous VS. Data analyses included stepwise Cox and logistic multivariate regression modeling. Among the 544 newly diagnosed PWH, mean age was 35, 76% were male, 46% non-Hispanic Black, 40% Hispanic/other. Overall, 35% screened positive for SU and 41% for MI. A positive SU (odds ratio (OR) 0.66, p = 0.04) or MI (OR 0.65, p = 0.03) SAMISS screening was associated with lower retention in care in univariate analysis, but was not statistically significant after adjusting for other variables. Positive SAMISS screening for SU and MI were both associated with reduced continuous VS in univariate and multivariate analyses (SU: adjusted OR (aOR) 0.67, p = 0.05; MI: aOR 0.66, p = 0.03). SAMISS is a useful tool for prospectively identifying individuals at risk for low retention in care and for not achieving sustained VS. Future interventions guided by SAMISS may improve HIV care continuum outcomes.
Literatur
2.
Zurück zum Zitat The White House. National HIV/AIDS Strategy for the United States 2022–2025, 2021. The White House. National HIV/AIDS Strategy for the United States 2022–2025, 2021.
8.
Zurück zum Zitat Relf MV, Holt WLH, Nyblade L, Ellis Caiola L C. A Review of the State of the Science of HIV and Stigma: Context, Conceptualization, Measurement, Interventions, Gaps, and, Priorities F. J Assoc Nurses AIDS Care. 2021;32(3):392–407. https://doi.org/10.1097/jnc.0000000000000237. [published Online First: Epub Date]|. Relf MV, Holt WLH, Nyblade L, Ellis Caiola L C. A Review of the State of the Science of HIV and Stigma: Context, Conceptualization, Measurement, Interventions, Gaps, and, Priorities F. J Assoc Nurses AIDS Care. 2021;32(3):392–407. https://​doi.​org/​10.​1097/​jnc.​0000000000000237​. [published Online First: Epub Date]|.
14.
Zurück zum Zitat Algarin AB, Sheehan DM, Varas-Diaz N, et al. Enacted HIV-Related Stigma’s association with anxiety & Depression among people living with HIV (PLWH) in Florida. AIDS Behav. 2021;25(1):93–103. [published Online First: Epub Date]|.CrossRefPubMedPubMedCentral Algarin AB, Sheehan DM, Varas-Diaz N, et al. Enacted HIV-Related Stigma’s association with anxiety & Depression among people living with HIV (PLWH) in Florida. AIDS Behav. 2021;25(1):93–103. [published Online First: Epub Date]|.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Crockett KB, Kalichman SC, Kalichman MO, Cruess DG, Katner HP. Experiences of HIV-related discrimination and consequences for internalised stigma, depression and alcohol use. Psychol Health. 2019;34(7):796–810. [published Online First: Epub Date]|.CrossRefPubMedPubMedCentral Crockett KB, Kalichman SC, Kalichman MO, Cruess DG, Katner HP. Experiences of HIV-related discrimination and consequences for internalised stigma, depression and alcohol use. Psychol Health. 2019;34(7):796–810. [published Online First: Epub Date]|.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Bengtson AM, Pence BW, Mimiaga MJ, Gaynes BN, Moore R, Christopoulos K, et al. Depressive symptoms and Engagement in Human Immunodeficiency Virus Care following antiretroviral therapy initiation. Clin Infect Dis. 2019;68(3):475–81. https://doi.org/10.1093/cid/ciy496. [published Online First: Epub Date]|.CrossRef Bengtson AM, Pence BW, Mimiaga MJ, Gaynes BN, Moore R, Christopoulos K, et al. Depressive symptoms and Engagement in Human Immunodeficiency Virus Care following antiretroviral therapy initiation. Clin Infect Dis. 2019;68(3):475–81. https://​doi.​org/​10.​1093/​cid/​ciy496. [published Online First: Epub Date]|.CrossRef
21.
Zurück zum Zitat Pence BW, Mills JC, Bengtson AM, Gaynes BN, Breger TL, Cook RL, et al. Association of increased chronicity of Depression with HIV Appointment Attendance, Treatment Failure, and Mortality among HIV-Infected adults in the United States. JAMA Psychiatry. 2018;75(4):379–85. https://doi.org/10.1001/jamapsychiatry.2017.4726. [published Online First: Epub Date]|.CrossRef Pence BW, Mills JC, Bengtson AM, Gaynes BN, Breger TL, Cook RL, et al. Association of increased chronicity of Depression with HIV Appointment Attendance, Treatment Failure, and Mortality among HIV-Infected adults in the United States. JAMA Psychiatry. 2018;75(4):379–85. https://​doi.​org/​10.​1001/​jamapsychiatry.​2017.​4726. [published Online First: Epub Date]|.CrossRef
24.
Zurück zum Zitat Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114(7):573–80. https://doi.org/10.1016/s0002-9343(03)00093-7. [published Online First: Epub Date]|.CrossRef Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114(7):573–80. https://​doi.​org/​10.​1016/​s0002-9343(03)00093-7. [published Online First: Epub Date]|.CrossRef
27.
Zurück zum Zitat Breuer E, Stoloff K, Myer L, Seedat S, Stein DJ, Joska JA. The validity of the substance abuse and Mental Illness Symptom Screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa. AIDS Behav. 2014;18(6):1133–41. https://doi.org/10.1007/s10461-014-0698. -y[published Online First: Epub Date]|.CrossRef Breuer E, Stoloff K, Myer L, Seedat S, Stein DJ, Joska JA. The validity of the substance abuse and Mental Illness Symptom Screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa. AIDS Behav. 2014;18(6):1133–41. https://​doi.​org/​10.​1007/​s10461-014-0698. -y[published Online First: Epub Date]|.CrossRef
30.
Zurück zum Zitat Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The Composite International Diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069–77. https://doi.org/10.1001/archpsyc.1988.01800360017003. [published Online First: Epub Date]|.CrossRef Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, et al. The Composite International Diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45(12):1069–77. https://​doi.​org/​10.​1001/​archpsyc.​1988.​01800360017003. [published Online First: Epub Date]|.CrossRef
31.
Zurück zum Zitat Administration HRaS. HIV/AIDS Bureau Performance Measures. 2019. Administration HRaS. HIV/AIDS Bureau Performance Measures. 2019.
33.
Zurück zum Zitat Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113–7. Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital signs: HIV diagnosis, care, and treatment among persons living with HIV–United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113–7.
40.
41.
Zurück zum Zitat Sohail M, Long DM, Batey DS, Mugavero MJ, Ojesina AI, Levitan EB. Partnership status and time to viral suppression and sustained viral suppression among newly diagnosed heterosexual people with HIV. Int J STD AIDS. 2022;33(4):347–54. https://doi.org/10.1177/09564624211065227. [published Online First: Epub Date]|.CrossRef Sohail M, Long DM, Batey DS, Mugavero MJ, Ojesina AI, Levitan EB. Partnership status and time to viral suppression and sustained viral suppression among newly diagnosed heterosexual people with HIV. Int J STD AIDS. 2022;33(4):347–54. https://​doi.​org/​10.​1177/​0956462421106522​7. [published Online First: Epub Date]|.CrossRef
50.
Zurück zum Zitat Centers for Disease Control and Prevention. HIV Surveillance Report. 2019;32. Centers for Disease Control and Prevention. HIV Surveillance Report. 2019;32.
51.
Zurück zum Zitat Centers for Disease Control and Prevention. NCHHSTP AtlasPlus. Centers for Disease Control and Prevention. NCHHSTP AtlasPlus.
55.
Zurück zum Zitat Arnold EA, Rebchook GM, Kegeles SM. Triply cursed’: racism, homophobia and HIV-related stigma are barriers to regular HIV testing, treatment adherence and disclosure among young Black Gay Men. Cult Health Sex. 2014;16(6):710–22. [published Online First: Epub Date]|.CrossRefPubMedPubMedCentral Arnold EA, Rebchook GM, Kegeles SM. Triply cursed’: racism, homophobia and HIV-related stigma are barriers to regular HIV testing, treatment adherence and disclosure among young Black Gay Men. Cult Health Sex. 2014;16(6):710–22. [published Online First: Epub Date]|.CrossRefPubMedPubMedCentral
Metadaten
Titel
Association Between Substance Abuse and Mental Illness Symptoms Screener (SAMISS) Scores and HIV Care Continuum Outcomes in People Newly Diagnosed with HIV in the US South
verfasst von
Manal Ahmed
Ank E. Nijhawan
Ang Gao
Chul Ahn
Jeremy Y Chow
Publikationsdatum
16.02.2024
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 5/2024
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-024-04287-1

Weitere Artikel der Ausgabe 5/2024

AIDS and Behavior 5/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.